Jump to: [Chinese Items]   [0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] or enter the first few letters:

Showing items 2371-2380 of 12972. (1298 Page(s) Totally) << < 233 234 235 236 237 238 239 240 241 242 > >> View [10|25|50] records per page

Date	Title	Relation
2022-06	Clinical implications of differential functional capacity between tissue-specific human mesenchymal stromal/stem cells	The FEBS Journal. 2023 Jun;290(11):2833-2844.
2011-12	Clinical implications of high MET gene dosage in non-small cell lung cancer patients without previous tyrosine kinase inhibitor treatment	Journal of Thoracic Oncology. 2011 Dec;6(12):2027-2035.
2015-02-13	Clinical implications of species identification in monomicrobial Aeromonas bacteremia	PLoS ONE. 2015 Feb 13;10(2):Article number e0117821.
2022-07-31	Clinical manifestation, management, and outcomes in patients with COVID-19 vaccine-induced acute encephalitis: Two case reports and a literature review	Vaccines. 2022 Jul 31;10(8):Article number 1230.
2024-06	Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies	Journal of Microbiology, Immunology and Infection. 2024 Jun;57(3):403-413.
2023-03-29	Clinical manifestations and risk factors of campylobacter gastroenteritis in children in Taiwan	Biomedical Journal. 2023 Mar 30;46(6):Article number 100590.
2017-08-26	Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014	Journal of Microbiology, Immunology, and Infection. 2017 Aug 26;52(4):612-619.
2017-11	Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014	International Journal of Antimicrobial Agents. 2017 Nov;50(Suppl. 2):S156-S157.
2010-09	Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteremia	Journal of Infection. 2010 Sep; 61(3):219-227.
2024-08-28	Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab	Journal of Clinical Oncology. 2024 Aug 28;Article in Press.

Showing items 2371-2380 of 12972. (1298 Page(s) Totally) << < 233 234 235 236 237 238 239 240 241 242 > >> View [10|25|50] records per page